Back to News
Market Impact: 0.42

Cantor Fitzgerald raises FormFactor stock price target on demand By Investing.com

FORM
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsCorporate Guidance & OutlookMarket Technicals & FlowsInvestor Sentiment & Positioning
Cantor Fitzgerald raises FormFactor stock price target on demand By Investing.com

Cantor Fitzgerald raised FormFactor’s price target to $175 from $125 and reiterated Overweight, citing strengthening demand and seven upward EPS revisions ahead of earnings in two days. FormFactor also recently beat Q4 2025 expectations with EPS of $0.46 versus $0.35 consensus and revenue of $215.2 million versus $210.25 million, although the stock fell after the report. The shares have surged 254% over six months and 447% over one year, but valuation remains elevated at 76x forward EPS and a P/E of 227.

Analysis

FORM is increasingly behaving like a classic scarcity-to-multiple expansion story rather than a clean fundamentals trade. When a name is already priced for perfection, the marginal buyer is usually not a new fundamental investor but an index/quant follower reacting to momentum, analyst revisions, and the expectation of continued “beats plus raises.” That makes the next 1-2 earnings windows unusually important: if management merely confirms demand, the stock can continue to grind higher; if commentary introduces even modest evidence of capacity friction or delayed ramp benefits, the multiple can compress quickly because expectations have outrun near-term earnings power. The deeper second-order effect is that FormFactor’s strength may be masking an industry bottleneck rather than broadening end-market health. If customers are pulling in orders ahead of expected capacity expansion, the near-term winners are adjacent equipment and consumables suppliers with less single-site ramp risk; the losers are peers whose valuation support depends on the same AI/advanced-node capital intensity but lack a visible capacity release valve. In other words, FORM’s setup is bullish for the supply chain optics, but it also increases the odds of a “good news, limited upside” reaction if investors realize the earnings step-up is capped before the next capacity inflection. The contrarian read is that the market is paying for the optionality of 2030 earnings today, which is a fragile trade if 2027 constraints slip or if Analyst Day fails to expand the TAM narrative. A stock at this valuation can still outperform for months, but the asymmetry is now less about upside to a higher target and more about the probability of a sharp drawdown on any guidance disappointment. The key tell will be whether management can translate demand commentary into a credible glide path for margins and capacity conversion; without that, the story remains momentum-supported but numerically over-extended. Catalyst timing matters: the next 48 hours is a sentiment event, the following 2-6 weeks is an Analyst Day/event-driven multiple test, and the 12-24 month window is about whether the ramp is real enough to justify current expectations. Any deceleration in upward revisions, or even a neutral quarter paired with cautious capacity language, could force de-grossing from fast-money holders who are long the trend, not the business.